MAJORITY SALE TISSO

Deal Announcement

DEAL ANNOUNCEMENT | OX8 CORPORATE FINANCE ACTS AS EXCLUSIVE ADVISOR TO THE SHAREHOLDERS OF TISSO NATURPRODUKTE GMBH ON THE MAJORITY SALE TO AFINUM

Aschaffenburg / Wenden / Munich, 24 September 2021

ox8 Corporate Finance exclusively advised the shareholders of TISSO Naturprodukte GmbH (“TISSO”) on the majority sale to Afinum Achte Beteiligungsgesellschaft mbH & Co. KG (“Afinum”). In the course of the transaction, the previous shareholders Albert Hesse and Markus Junge as well as other key employees have significantly invested in the company.

Since its foundation in 1999 by Albert Hesse, TISSO has been developing and producing high-quality food supplements “made in Germany”. The company has its own laboratory and research & development team based in Wenden, Germany. The “TISSO” brand represents a holistic diagnosis and therapy concept, practiced by therapists throughout Germany.

In addition to its own product portfolio, TISSO is increasingly acting as a B2B service provider, where the company uses its many years of experience in the field of innovative food supplements offering its customers a holistic service approach, starting with product development and extending to the management of sales and logistics functions.

The company has grown strongly in recent years and plans to significantly expand its capacities by opening a second production site. To optimally prepare the company for this next stage, the shareholders Albert Hesse and Markus Junge selected Afinum as the perfect growth partner after a competitive process.

Markus Junge, shareholder of TISSO Naturprodukte GmbH, is delighted: “The partnership with Afinum is a milestone in the further development of the company. The imminent opening of our second production site offers excellent conditions to benefit over-proportionally from the growth of the nutritional supplements market in the future. Nevertheless, we are aware of the complexity of this undertaking and are very happy to have Afinum as a highly experienced growth partner at our side. We are already very much looking forward to the upcoming collaboration and are excited about what the future holds.”

“ox8 Corporate Finance provided us with excellent support at all times during the very intense process and exceeded our high expectations. The team acted in a highly professional, committed, and structured manner. On top of that, this happened in an extremely pleasant atmosphere throughout. We are therefore more than happy to have chosen ox8 as our M&A advisor.”

About TISSO (www.tisso.de)

TISSO Naturprodukte GmbH was founded in 1999 in Wenden, Germany and currently has approximately 100 employees. With its in-house laboratory as well as research & development department, the company develops and produces high-quality nutritional supplements. All product formulas are integrated into a comprehensive nutritional concept. In addition to its proprietary brand products, TISSO also supports customers as a B2B service provider with a holistic approach.

About Afinum (www.afinum.de)

Afinum is an independent investment company based in Munich, focusing on medium-sized companies in the German-speaking region, across all sectors. Since its foundation in 2000, Afinum has invested in approximately 80 companies via its managed funds.

About ox8 Corporate Finance (www.ox8-cf.com)

ox8 Corporate Finance is an independent corporate finance boutique founded in 2018 by experienced M&A specialists. Corporate finance advisory services are offered with a focus on M&A as well as Growth Capital in the Software/ Saas, Digital Commerce, Technology/ IT services and Healthcare sectors. The team has an excellent international network to financial investors and strategic buyers. ox8 Corporate Finance has offices in Frankfurt am Main and Aschaffenburg.